ArticleFrontiers in endocrinology2025
Multi-feature integrated machine learning prediction model for early nephropathy in elderly living with type 2 diabetes mellitus.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: To develop and validate a multi-feature machine learning (ML) model for early diabetic nephropathy (DN) prediction in elderly living with type 2 diabetes mellitus (T2DM), incorporating clinical indicators, symptoms of traditional Chinese medicine (TCM), and ultrasonic imaging features. Methods: The valid data (including clinical indicators, TCM symptoms, and ultrasonic imaging features) of 786 patients was retained, and the data were divided into training and validation set. Three models were constructed to examine the model's performance. The optimal indicators were selected for seven ML. Performance was assessed using accuracy, precision, recall, F1 score, and the area under the receiver operating characteristic curve (AUC). The subgroup analysis was conducted based on age. Results: The multi-feature model, combining clinical data, TCM symptoms, and ultrasound imaging, demonstrated the best performance. Among the ML algorithms, RF exhibited superior performance with an AUC of 0.894, sensitivity of 0.667, specificity of 0.877, precision of 0.769, recall of 0.667, and F1 score of 0.714 in the validation set. Subgroup analysis revealed that the AUC values exceed 0.7 in each group. Conclusion: This study is the first to incorporate TCM symptoms and ultrasound imaging features into a predictive model for early DN in elderly living with T2DM. The models demonstrated strong predictive performance across different age groups. These findings underscore the potential of early screening, prevention, and intervention in improving outcomes for elderly living with T2DM, offering a novel approach to managing diabetic nephropathy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.